about us

We are a bioinformatics and multi-omics company

We are driven forward by a vision of a future where cancer is curable.

Leadership

UDX has an international team of  scientists, researchers, clinical managers and tech entrepreneurs inspired by its mission to create a future where cancer is curable.

Juan Martínez Barea
Co-Founder and Executive President

Juan is a successful tech entrepreneur who has launched more than 100 start-ups, including the first high-tech start-up accelerator in Southern Europe. He received an MBA from the Massachusetts Institute of Technology (MIT), an M.S. in Economics from Ecole Centrale in Paris, and M.S. and B.S. in Industrial Engineering from Universidad de Sevilla. He was selected as an Endeavor Entrepreneur in 2021.

Marko Bitenc
Co-Founder and Chief Innovation Officer

Marko is a successful tech entrepreneur with a passion for launching and leading companies in the genetics and bioinformatics industries. Before launching Universal DX, he founded GenePlanet, a biotech start-up focusing on preventive genetic testing. He received a B.S. in Biotechnology from the University of Ljubljana and an M.S. in Biotechnology from Wageningen University & Research. He was the winner of the MIT iGEM synthetic biology competition in Health and Medicine and selected as an Endeavor Entrepreneur in 2021.

Antonio Carro
Chief Executive Officer

Antonio brings more than 25 years of experience launching and leading new technology companies, including one publicly-traded on the NASDAQ. In addition to his experience as an entrepreneur and chief executive, he spent 8 years at McKinsey & Co where he leaded the EU Telco practice. He received an MBA from the Institut Europeen d’Administration des Affaires (INSEAD).

Christian Hense
Managing Director and Chief Operating Officer

Christian brings more than 15 years of experience in Life Sciences to his role. Formerly, he was a member of Boston Consulting Group’s Operations and Healthcare team and led the company’s recruiting efforts. He received an MBA from the Institut Europeen d’Administration des Affaires (INSEAD), and is a member of Handelsblatt Health Circle and was selected as Endeavor Entrepreneur in 2021.

Kristi Kruusmaa
Head of Research

Kristi brings more than 10 years of experience in biotechnology to her role. Her areas of expertise and study include genetics, cancer biology, liquid biopsy, method development and data analysis. At Universal DX, she is leading a multidisciplinary team in diagnostic product development focusing on GI tract cancers. She received a B.S. in Genetics and a M.S. in Biotechnology & Biochemistry from Tallinn University of Technology.

Ignacio López-Bravo
Chief Financial Officer

Ignacio brings more than 10 years of experience in financial services and management consulting to his role. Formerly, he held roles at global financial consulting firms Barclays Capital, PwC and Kearney. He received a B.S. in Business Administration from ICADE (Madrid) and HEC Montreal, an MBA from the Institut Europeen d’Administration des Affaires (INSEAD). He was selected at Singularity University’s Global Startup Program 2019 with UDX.

Federico A. Monzón
Chief Medical Officer

Federico is a medical executive with more than 18 years of experience translating novel genomic technologies into clinical molecular tests in both academic and industry environments. A Board-certified Molecular Pathologist, he received an MD from the National Autonomous University of Mexico (UNAM), Pathology at Thomas Jefferson University (USA) and Molecular Pathology at University of Pittsburgh (USA). He previously served as the President of the Association for Molecular Pathology (AMP).

Álvaro Leiva
Head of Operations

Alvaro brings more than 10 years of experience in management consulting, with a focus on advising tech start-ups. He received an MBA from San Telmo Business School and also completed The Executive Program on Entrepreneurship at MIT. He received a B.A. in Business Administration from the University of North Florida.

Paola Hurtado
Head of Strategic Projects

Paola brings more than 15 years of experience in biotechnology and chemistry applications, including project and clinical and laboratory data management. She earned a Ph.D. in Biotechnology and a B.S. in Environmental Sciences from University Pablo de Olavide as well as an MBA from ThePowerMBA.

Inmaculada García
Regulatory Affairs and Quality Assurance Manager

Immaculada has more than 10 years of experience in Regulatory Affairs and Quality Assurance in the fields of IVD products and Medical Devices, which has informed her extensive knowledge of European and US IVD regulations and related ISO standards. She earned an M.S. in quality management systems (EQF) and a B.A. in Tourism Business Management from the University of Birmingham.

Purificación Morcillo
Technical Project Manager

Purificación brings 10 years of laboratory experience as an analyst and project manager including an organic and three bioanalysis laboratories and 5 years of clinical data experience. She holds a B.S. in Chemistry and an M.S. in Quality Assurance and Environmental Management from the University of Murcia.

Antonio Adsuar
Data Science Manager, IT Manager

Antonio brings more than 14 years of experience in architecture design and implementation of AI-based solutions, focusing on Machine Learning applied to the life sciences industry and Natural Language Processing (NLP). He holds an M.S. in Artificial Intelligence from the University of Seville and a B.S. in Computer Science Engineering from the University of Alicante.

Scientific Advisors

Dr. Uri Ladabaum
Stanford University, Palo Alto, US

Head of Colorectal Cancer Screening Program

Dr. Michael Roehrl
Dr. Michael Roehrl, New York City, US

Director Precision Pathology Biobanking Center MSKCC; Specialized in diagnosing gastrointestinal diseases such as colorectal and pancreatic cancers.

Dr. Toni Castells
Clinic Hospital, Barcelona, Spain

Medical Director. Head of Colorectal Cander Screening Program.

Dr. Josep Tabernero
Vall d´Hebron Hospital, Barcelona, Spain

Director of the Institute of Oncology, ESMO President.

Dr. Thomas Rösch
Gastroenterologist, Hamburg, DE

Medical Director. Center for Endoscopy UKE Hamburg; Member of Global Clinical Trial Board Epigenomics

Dr. Siegbert Faiss
Gastroenterologist, Berlin, DE

Medical Director. Gastroenterology of Sana Klinikum Lichtenberg, Site Principal Investigator Germany; Member of Global Clinical Trial Board Epigenomics.

Dr. James Kinross
Colorectal Cancer Surgeon, London, UK

Colorectal Surgeon and Clinical Senior Lecturer in Colorectal Surgery. Member of Faculty of Medicine, Department of Surgery & Cancer at Imperial College London.

R&D Partners

Clinical Partners

+100

CLINICAL INSTITUTIONS

6

Countries

We have built a network of >100 hospitals in the U.S. and across Europe with whom we have recruited >12K samples and work with more than hundred gastrointestinal clinical teams. We are currently running an observational study, USOPTIVAL, for which we are recruiting 1,200 patients at >15 US hospitals.

Acknowledgements

careers

Work With Us

We are on a mission to transform cancer into a preventable and curable disease through the development of minimally-invasive, blood-based tests that can detect the disease in its earliest stages and forms.

Our team is made up of international, multi-disciplinary experts all working together to achieve this mission. If you’d like to join us, we’d love to hear from you.

Apply now